LC
AGN

Landaas & Company’s Allergan plc AGN Stock Holding History

Landaas & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-122
Closed -$20K – 336
2018
Q2 		$20K Buy
+122
New +$19.6K 0.02% 226
2018
Q1 		– Sell
-122
Closed -$20K – 332
2017
Q4 		$20K Hold
122
– – 0.02% 218
2017
Q3 		$25K Buy
+122
New +$28.4K 0.02% 201

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Landaas & Company's AGN Position: Q3 2018 in Review

Landaas & Company sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 122 shares — an estimated $20K sold.

Landaas & Company first reported a position in AGN in Q3 2017 and held it in 3 quarters. The position peaked at $25K in Q3 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Landaas & Company reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Landaas & Company sold 122 Allergan plc shares in Q3 2018, an estimated $20K.
  • Landaas & Company first reported a position in Allergan plc in Q3 2017 and held it in 3 quarters.
  • Landaas & Company's Allergan plc position peaked at $25K in Q3 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.